What happens if you drink alcohol while taking vistaril?
What happens if you drink alcohol while taking vistaril?
Alcohol can increase the nervous system side effects of hydrOXYzine such as dizziness, drowsiness, and difficulty concentrating. Some people may also experience impairment in thinking and judgment. You should avoid or limit the use of alcohol while being treated with hydrOXYzine.
What happens when you mix Xanax and hydrOXYzine?
Interactions between your drugs Using ALPRAZolam together with hydrOXYzine may increase side effects such as dizziness, drowsiness, confusion, and difficulty concentrating. Some people, especially the elderly, may also experience impairment in thinking, judgment, and motor coordination.
Can vistaril make you pass out?
Hydroxyzine may cause a condition that affects the heart rhythm (QT prolongation). QT prolongation can rarely cause serious (rarely fatal) fast/irregular heartbeat and other symptoms (such as severe dizziness, fainting) that need medical attention right away.
Is it OK to drink alcohol with hydrOXYzine?
Mixing hydroxyzine and alcohol may be an unsafe choice because the combination can worsen the risk of side effects like drowsiness. Overall, it’s best to avoid alcohol use if you take hydroxyzine.
How long after taking Vistaril can you drink alcohol?
Unfortunately, there’s no specific timeline for when alcohol can be safely consumed after stopping hydroxyzine. Since hydroxyzine is used for anxiety, it’s important to be aware of the risk of replacing it with alcohol to treat your symptoms.
Can I take Xanax with Vistaril?
Are Xanax and hydroxyzine the same?
Hydroxyzine and Xanax belong to different drug classes. Hydroxyzine is an antihistamine with anticholinergic (drying) and sedative properties and Xanax is an anti-anxiety medication in the benzodiazepine class. A brand name for hydroxyzine is Vistaril.
Is vistaril bad for your heart?
Information to healthcare professionals Hydroxyzine has the potential to block hERG channels and other types of cardiac channels, resulting in a potential risk of QT interval prolongation and cardiac arrhythmia events. This potential risk was confirmed by clinical and post-marketing data.
